Evidence map›Paper›PMID 33928045›Full record

ArticleFrontiers in cellular and infection microbiology2021

Modulation of Immune Response to

Jonathon Keck, James P Chambers, Jieh-Juen Yu, Xingguo Cheng, Lane K Christenson, M N Guentzel, Rishein Gupta, Bernard P Arulanandam

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Genes · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Jonathon KeckSouth Texas Center for Emerging Infectious Diseases, Department of Biology, University of Texas at San Antonio, San Antonio, TX, United States.
James P ChambersSouth Texas Center for Emerging Infectious Diseases, Department of Biology, University of Texas at San Antonio, San Antonio, TX, United States.
Jieh-Juen YuSouth Texas Center for Emerging Infectious Diseases, Department of Biology, University of Texas at San Antonio, San Antonio, TX, United States.
Xingguo ChengDepartment of Materials & Bioengineering, Southwest Research Institute, San Antonio, TX, United States.
Lane K ChristensonDepartment of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, KS, United States.
M N GuentzelSouth Texas Center for Emerging Infectious Diseases, Department of Biology, University of Texas at San Antonio, San Antonio, TX, United States.
Rishein GuptaSouth Texas Center for Emerging Infectious Diseases, Department of Biology, University of Texas at San Antonio, San Antonio, TX, United States.
Bernard P ArulanandamSouth Texas Center for Emerging Infectious Diseases, Department of Biology, University of Texas at San Antonio, San Antonio, TX, United States.
Texas Center for Infectious Disease · USSouthwest Research Institute · USUniversity of Kansas Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previously, our laboratory established the role of small, noncoding RNA species

Indexed as

Chlamydia InfectionsChlamydia muridarumMicroRNAsAnimalsChemokinesImmunityMiceChemokinesMicroRNAsMirn135 microRNA, mousecell migrationChlamydiadendritic cellsmicroRNAmiR135a

Identifiers

PMID33928045
PMCPMC8076868
OpenAlexW3154420003

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.